Citations

Clear

1446 citation(s) found for "Howard, F".

Introduction
ROME, HOWARD P., Rome, Howard P

Mayo Clinic

American Journal of Psychiatry | December 17, 2014 | Volume: 123 | Issue: 2 | Pages: 173-174

10.1176/ajp.123.2.173 | PMID 5329307 Get It

The Presidential Address: Psychiatry and Social Change Circa 1966
Rome, Howard P

Mayo Clinic

American Journal of Psychiatry | December 17, 2014 | Volume: 123 | Issue: 1 | Pages: 1-11

10.1176/ajp.123.1.1 | PMID 5935185 Get It

ON NOVALESCENCE: A RESPONSE TO THE PRESIDENTIAL ADDRESS OF DR. DANIEL BLAIN
Rome, Howard P

Mayo Clinic

American Journal of Psychiatry | December 17, 2014 | Volume: 122 | Issue: 1 | Pages: 13-15

10.1176/ajp.122.1.13 Get It

AGE AND SEX DIFFERENCES RELATED TO MMPI RESPONSE FREQUENCY IN 25,000 MEDICAL PATIENTS
Swenson, Wendell M., Rome, Howard P, PEARSON, JOHN S.

Mayo Clinic

American Journal of Psychiatry | December 17, 2014 | Volume: 121 | Issue: 10 | Pages: 988-995

10.1176/ajp.121.10.988 | PMID 14272998 Get It

FRANCIS J. BRACELAND, M. D., EIGHTY-THIRD PRESIDENT, 1956-1957: A BIOGRAPHICAL SKETCH
Rome, Howard P

Mayo Clinic

American Journal of Psychiatry | December 17, 2014 | Volume: 114 | Issue: 1 | Pages: 10-13

10.1176/ajp.114.1.10 | PMID 13424745 Get It

THE PSYCHOLOGICAL RESPONSE TO ACTH, CORTISONE, HYDROCORTISONE, AND RELATED STEROID SUBSTANCES
Rome, Howard P, Braceland, Francis J

Mayo Clinic

American Journal of Psychiatry | December 17, 2014 | Volume: 108 | Issue: 9 | Pages: 641-651

10.1176/ajp.108.9.641 | PMID 14903192 Get It

The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
Kuhn, Peer‐Hendrik , Laurent, Sarah , Hauck, Stefanie M. , Berer, Kerstin, Wendlinger, Simone A., Krumbholz, Markus , Khademi, Mohsen , Olsson, Tomas , Dreyling, Martin , Pfister, H.-W., Alexander, Tobias , Hiepe, Falk , Kümpfel, Tania , Wekerle, Hartmut , Hohlfeld, Reinhard , Meinl, Edgar , Crawford, Howard C, Hoffmann, Franziska S. , Crawford, Howard C. , Lichtenthaler, Stefan F.

Mayo Clinic

The Journal of Immunology | December 11, 2014 | Volume: 194 | Issue: 2 | Pages: 542-552

10.4049/jimmunol.1402070 | PMID 25505277 Get It

Abstract BAFF and a proliferation-inducing ligand (APRIL), which control B cell homeostasis, are therapeutic targets in autoimmune diseases. TACI-Fc (atacicept), a soluble fusion protein containing the extracellular domain of the BAFF–APRIL receptor TACI, was applied in clinical trials. However, disease activity in multiple sclerosis unexpectedly increased, whereas in systemic lupus erythematosus, atacicept was beneficial. In this study, we show that an endogenous soluble TACI (sTACI) exists in vivo. TACI proteolysis involved shedding by a disintegrin and metalloproteinase 10 releasing sTACI from activated B cells. The membrane-bound stub was subsequently cleaved by γ-secretase reducing ligand-independent signaling of the remaining C-terminal fragment. The shed ectodomain assembled ligand independently in a homotypic way. It functioned as a decoy receptor inhibiting BAFF- and APRIL-mediated B cell survival and NF-κB activation. We determined sTACI levels in autoimmune diseases with established hyperactivation of the BAFF–APRIL system. sTACI levels were elevated both in the cerebrospinal fluid of the brain-restricted autoimmune disease multiple sclerosis correlating with intrathecal IgG production, as well as in the serum of the systemic autoimmune disease systemic lupus erythematosus correlating with disease activity. Together, we show that TACI is sequentially processed by a disintegrin and metalloproteinase 10 and γ-secretase. The released sTACI is an immunoregulator that shares decoy functions with atacicept. It reflects systemic and compartmentalized B cell accumulation and activation.
Management of Vascular Risk Factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
Voeks, Jenifer H. , Leimgruber, Pierre P., Mantese, Vito A., Timaran, Carlos H. , Chiu, David, Howard, Virginia J. , Hughes, Susan , Longbottom, Mary, Brott, Thomas G. , Meschia, James F. , Demaerschalk, Bart M. , Howard, Annie Green , Howard, Virginia J

Mayo Clinic

Journal of the American Heart Association | November 27, 2014 | Volume: 3 | Issue: 6 | Pages: No page available

10.1161/jaha.114.001180 | PMID 25428209 Get It

Background The Carotid Revascularization Endarterectomy Versus Stenting Trial ( CREST ) is a multicenter randomized trial of stenting versus endarterectomy in patients with symptomatic and asymptomatic carotid disease. This study assesses management of vascular risk factors. Methods and Results Management was provided by the patient's physician, with biannual monitoring results collected by the local site. Therapeutic targets were low‐density lipoprotein, cholesterol <100 mg/dL, systolic blood pressure <140 mm Hg, fasting blood glucose <126 mg/dL, and nonsmoking status. Optimal control was defined as achieving all 4 goals concurrently. Generalized estimating equations were used to compare risk factors at baseline with those observed in scheduled follow‐up visits for up to 48 months. In the analysis cohort of 2210, significant improvements in risk‐factor control were observed across risk factors for all follow‐up visits compared with baseline. At 48 months, achievement of the low‐density lipoprotein cholesterol goal improved from 59.1% to 73.6% ( P <0.001), achievement of the systolic blood pressure goal improved from 51.6% to 65.1% ( P <0.001), achievement of the glucose goal improved from 74.9% to 80.7% ( P =0.0101), and nonsmoking improved from 74.4% to 80.9% ( P <0.0001). The percentage with optimal risk‐factor control also improved significantly, from 16.7% to 36.2% ( P <0.001), but nearly 2 of 3 study participants did not achieve optimal control during the study. Conclusions Site‐based risk‐factor control improved significantly in the first 6 months and over the long term in CREST but was often suboptimal. Intensive medical management should be considered for future trials of carotid revascularization. Clinical Trial Registration URL: ClinicalTrials.gov. Unique identifier: NCT00004732.
Practice Patterns and Predictors of Followup Imaging after a Negative Bone Scan in Men with Castration Resistant Prostate Cancer: Results from the SEARCH Database
Sourbeer, Katharine N., Howard, Lauren E. , Moreira, Daniel M. , Amarasekara, Hiruni S., Chow, Lydia D., Cockrell, Dillon C. , Hanyok, Brian T. , Pratson, Connor L., Terris, Martha K. , Amling, Christopher L. , Hernandez, Rohini K. , Freedland, Stephen J. , Kane, Christopher J. , Aronson, William J. , Cooperberg, Matthew R , Howard, Lauren E

Mayo Clinic

Journal of Urology | November 17, 2014 | Volume: 193 | Issue: 4 | Pages: 1232-1238

10.1016/j.juro.2014.11.014 | PMID 25463986 Get It